Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review
Frontiers in Oncology · 19.11.2024 · 14
DOI: 10.3389/fonc.2024.1487467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 19.11.2024. Verfasst von Younghoon Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Gastrointestinal stromal tumors (GISTs) arise from the interstitial cells of Cajal, predominantly affecting the stomach and small intestine, with rare occurrences in the duodenum, rectum, and extraintestinal sites. Histologically, GISTs can present as spindle cells, epithelioid cells, or mixed morphologies, with immunohistochemical staining revealing expression of KIT (CD117) and discovered on GIST 1 (DOG1). Approximately 80% of GISTs harbor activating mutations in KIT or platelet derived growth factor receptor α (PDGFRA), which influence their clinical behavior and treatment response. SDH-deficient GISTs, associated with syndromes such as Carney triad and Carney–Stratakis syndrome, represent a distinct subgroup with unique characteristics and management challenges. The standard treatment includes surgery and imatinib for metastatic cases; however, resistance to tyrosine kinase inhibitors remains a significant hurdle, especially in pediatric and wildtype GISTs. This highlights the need for advanced therapeutic strategies and emphasizes the importance of molecular profiling in guiding treatment decisions and improving outcomes for GIST patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, Y., & Lee, S. H. (2024). Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1487467
Vancouver
Kim Y, Lee SH. Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1487467
BibTeX
@article{Kim2024,
author = {Kim, Younghoon and Lee, Sung Hak},
title = {Pathologic diagnosis and molecular features of gastrointestinal stromal tumors: a mini-review},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1487467}
}
EUVIMED